Both in Pharmaceuticals
SIGA Technologies vs Evommune
Over the past year SIGA returned −63.9% and EVMN returned −70.3%; their daily moves had a correlation of 0.23.
SIGA −63.9% EVMN −70.3%Growth of $1, one year, split-adjusted
| Metric | SIGA | EVMN |
|---|---|---|
| Price | $2.95 | $6.01 |
| Market cap | $212.0M | $218.1M |
| Today | −2.96% | −10.70% |
| 1 month | −12.7% | −13.2% |
| 6 months | −36.3% | −74.6% |
| Year to date | −51.7% | −64.9% |
| 1 year | −64.5% | — |
| Revenue growth (YoY) | −49.5% | — |
| Gross margin | 57.2% | — |
| Net margin | 30.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.0× | — |
| Net cash | $117.6M | $200.4M |
| Dividend yield | 20.34% | — |
| Volatility (60d) | 42.5% | 87.2% |
| Short % of float | 8.8% | 16.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).